# OnCo record paper-hera-b31-n9831-lancet-2017-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hera-b31-n9831-lancet-2017-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hera-b31-n9831-lancet-2017-update" ;
  schema:name "11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial"@en ;
  schema:description "Later report from the HERA trial registered as NCT00045032, in The Lancet (2017); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-hera-b31-n9831-lancet-2017-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s0140-6736(16)32616-2>, <https://pubmed.ncbi.nlm.nih.gov/28215665/>, <https://europepmc.org/article/MED/28215665>, <https://clinicaltrials.gov/study/NCT00045032> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s0140-6736(16)32616-2> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Cameron D, Piccart-Gebhart MJ, Gelber RD, et al." ;
  onco:trials <https://onco.cc/trials/hera-b31-n9831/> ;
  onco:journals <https://onco.cc/journals/lancet/> .